Agreed. NP said they hope to hear from the FDA.
So
Agreed. NP said they hope to hear from the FDA.
So many people on this board hear and assume stuff that was never said or even implied. If you trust Margaret from the 4th floor communications department in the bowels of the FDA to be as pumped up as you are about Leronlimab, you have another thing coming. The federal govt is full of people punching the clock, justifying their jobs. They will follow process no matter what. (Governor Lepetomane : We've gotta protect our phoney baloney jobs, gentlemen!)
Throwing stones at NP over things like this is like beating your head against the wall. I envision the process of getting a drug approved as your worst govt experience of dealing with some bureaucracy and mulitply it by 1000. (i have done foreign adoptions and dealt with some of the most idiotic worker bees in govt trying to get approvals in the construction/permitting trades... it can be maddening and trust me there is no common sense) You have to suck up the idiocy and just say "yes sir, we'll get that to you..." over and over and over. Nothing makes sense and it drives you crazy.
Now envision that and then having all your investors question your every move and every utterance. then take each utterance and imply, assume things that were clearly not even intended. I seriously cannot comprehend some of the things people say NP promised or said after listing to the same webinar.
Does NP have a hopeful spirit and can be too optimistic at times? Yes he can, but if you have been around more than 1 month you know that is who he is. I worry about some here and how they can function in life based on the difference between what NP says and what they hear.
Just relax. You invested for the science and know where this leads. Have patience knowing how far NP has taken this company. Any amount bellyaching or whining of ANYONE on this board isnt going to have any effect on the progress or process of getting approval of the FDA. You hope for a buyout of 30$ by handing this over to some BP behemoth, or let this process play out and see a return of multiples of 30$.
and of course IMO. GLTA
6
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Dawn of the Agent Web Well, here we are, standing at the cusp of a new digital frontier, folks. This ain't just another buzzword parade; this is the Open Agentic Web Challenge, courting developers with a $13K carrot to craft an interoperable playground for AI agents. Big names like Cognizant AI Lab, MIT Media Lab, and others are leading the charge. No small-time...
Continue Reading
Reaching the Century Mark in Retail Ah, retail. It's a rough-and-tumble world out there, but today we're tipping our hats to The Spice & Tea Exchange® for hitting the 100-store milestone. This brand's fresh out the kitchen with a shiny new store in Eureka Springs, Arkansas, marking a big moment for a franchise that's become a hot commodity in the realm of spices and...
Continue Reading
Breaking Away From the Subscription Cycle When's the last time you saw a price that didn't make you groan? Halfpricesoft.com seems to have stumbled upon the magic number with their $169 flat-rate deal. You might think this feels like one of those golden eggs in a nest of subscription fatigue—and you'd be right. As inflation ramps up costs, especially for small...
Continue Reading
A Grim Scene Unfolds in Flatbush, Brooklyn Some days start with headlines you'd rather not see, and November 11, 2026, painted a picture straight out of a nightmare. A building went belly-up in the heart of Brooklyn's Flatbush neighborhood, leaving a tragic tally in its wake—8 dead, including two kids, and 18 others carrying the burden of injuries. We're staring down...
Continue Reading
Setting the Stage: Minerva Foods' Latest Report Walking through the jungle of financial statements, few things are clear-cut. Minerva Foods handed out its latest report, stirring both optimism and concern among the suits at the table. Here's the brass tacks of it: a 9.5% boost in net revenue drumming up R$56.2 billion over twelve months. Sounds solid, huh? Yet, lurking...
Continue Reading
FFR's Shot at Robotics Education Dominance You ever feel like a company is throwing everything but the kitchen sink at an opportunity? That's FF EAI Robotics for you—charging ahead with a hefty laundry list of tech ambitions. They've clocked in about $2.3 million in revenue from their newly acquired robotics wing for the first nine months of 2026, showing a 26% gross...
Continue Reading
Tellus Offers a Boost for Savers Battling Inflation Well, hotshot, if you thought the days of high returns on savings were long gone, tell that to Tellus. This proptech outfit just upped its Reserve Account annual percentage yield (APY) to a juicy 8.00%. That's a damn sight better than the pittance you'll get parking funds elsewhere. Just look at the numbers—consumer...
Continue Reading
Riding the Generational Equity Wave Here's a kicker for you—the housing game has warped in ways that have flummoxed even the sharpest minds nodding along at economic seminars. Elder millennials back in the early 30s bracket once rode high with those mythical low mortgage rates—magic numbers scratching the underbelly of 3%, if you can believe it. But in today's...
Continue Reading
The Wine Industry's Digital Splash Ah, the wonderful world of wine—a place where culture, taste, and that sweet bouquet of a well-aged vintage collide. It’s no secret that the wine industry is a cash cow, raking in more than $323 billion annually in the U.S. alone. Digital Information Resources (DIR), a savvy player in tech and media circles, decided this bubbling...
Continue Reading
Helping Veterans Transition to Business Ownership Veterans transitioning from military life to civilian business ventures can often feel like they're wading through a murky swamp. That's why FSC Franchise Co. is pitching in to make the path a whole lot clearer. They're pulling out all the stops by launching a new veterans program packed with savings and resources, built...
Continue Reading
Top 5 Most Recently Viewed Articles
Gulf Resources Enhances Production Capabilities Gulf Resources, Inc. (Nasdaq: GURE), a prominent manufacturer of bromine and crude salt products, recently made headlines with their strategic acquisition of additional land for salt fields in China. This announcement marks a pivotal development for the company as it seeks to strengthen its operational capacity and meet the...
Continue Reading
Bow River Capital Completes Exit from AbsenceSoft Investment Bow River Capital's Software Growth Equity Team has successfully completed the sale of AbsenceSoft to Luminate Capital, a notable growth buyout firm that specializes in enterprise SaaS companies. AbsenceSoft is a recognized leader in Leave and Accommodation Lifecycle Management, currently supporting over five...
Continue Reading
Omni-Lite Industries Secures New Five-Year Agreement Omni-Lite Industries Canada Inc. is excited to share that its subsidiary, Designed Precision Castings (DP Cast), has entered into a significant five-year agreement with a prominent global jet engine manufacturer. This pivotal agreement focuses on supplying precision castings for a variety of fixed and rotary wing...
Continue Reading
Allstate's Upcoming Announcement: What to Watch For Allstate Corporation (NYSE: ALL) is rolling in hot with a presentation at the Raymond James Institutional Investors Conference on March 2, 2026, at 6:30 a.m. CT. This ain’t just any conference, folks—this is where they spill the beans on the nitty-gritty of their operations and financial outlooks. Here’s the...
Continue Reading
CornNext-17: Innovative Solution to Plastic Pollution Corn Next has officially introduced CornNext-17, a pioneering bio-based material aimed at tackling the rampant plastic pollution issue. This revolutionary product not only serves practical purposes but also aligns with global sustainability efforts, positioning itself as a viable alternative to conventional plastics....
Continue Reading